Bernstein Initiates Coverage On Moderna with Market Perform Rating, Announces Price Target of $55

Benzinga · 10/17 16:39
Bernstein analyst Courtney Breen initiates coverage on Moderna (NASDAQ:MRNA) with a Market Perform rating and announces Price Target of $55.